Cargando…
Dexmedetomidine improved renal function in patients with severe sepsis: an exploratory analysis of a randomized controlled trial
BACKGROUND: Dexmedetomidine has been reported to improve organ dysfunction in critically ill patients. In a recent randomized controlled trial (Dexmedetomidine for Sepsis in Intensive Care Unit (ICU) Randomized Evolution [DESIRE]), we demonstrated that dexmedetomidine was associated with reduced mor...
Autores principales: | Nakashima, Tsuyoshi, Miyamoto, Kyohei, Shima, Nozomu, Kato, Seiya, Kawazoe, Yu, Ohta, Yoshinori, Morimoto, Takeshi, Yamamura, Hitoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939335/ https://www.ncbi.nlm.nih.gov/pubmed/31908779 http://dx.doi.org/10.1186/s40560-019-0415-z |
Ejemplares similares
-
Utility of a prediction model for delirium in intensive care unit patients (PRE‐DELIRIC) in mechanically ventilated patients with sepsis
por: Miyamoto, Kyohei, et al.
Publicado: (2020) -
Effect of dexmedetomidine on inflammation in patients with sepsis requiring mechanical ventilation: a sub-analysis of a multicenter randomized clinical trial
por: Ohta, Yoshinori, et al.
Publicado: (2020) -
Effect of age on dexmedetomidine treatment for ventilated patients with sepsis: a post‐hoc analysis of the DESIRE trial
por: Sato, Tetsuya, et al.
Publicado: (2021) -
Comparison between midazolam and propofol in acute phase for ventilated patients with sepsis: a post‐hoc analysis of the DESIRE trial
por: Miyagawa, Noriko, et al.
Publicado: (2022) -
Effect of norepinephrine dosage on mortality in patients with septic shock
por: Yamamura, Hitoshi, et al.
Publicado: (2018)